Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rutger M van den Bor

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
BMC Medical Research Methodology|April 17, 2025
Cohort data with dropout: a simulation study comparing five longitudinal analysis methodsRebecca K Stellato, Rutger M van den Bor, Maria Schipper, et al.
Therapeutic Innovation & Regulatory Science|September 22, 2018
Efficient Source Data Verification Using Statistical Acceptance Sampling: A Simulation StudyRutger M van den Bor, Bas J Oosterman, Martinus B Oostendorp, et al.
Contemporary Clinical Trials Communications|April 27, 2018
Predicting enrollment performance of investigational centers in phase III multi-center clinical trialsRutger M van den Bor, Diederick E Grobbee, Bas J Oosterman, et al.
Journal of Clinical Epidemiology|April 17, 2017
A computationally simple central monitoring procedure, effectively applied to empirical trial data with known fraudRutger M van den Bor, Petrus W J Vaessen, Bas J Oosterman, et al.
ERJ Open Research|June 14, 2023
The RISE study protocol: resilience impacted by positive stressful events for people with cystic fibrosisEls van der Heijden, Rutger M van den Bor, Cornelis K van der Ent, et al.
American Heart Journal|April 12, 2024
Rationale and design for the randomized placebo-controlled double-blind trial studying the effect of single antiplatelet therapy (clopidogrel) versus dual antiplatelet therapy (clopidogrel/acetylsalicylic acid) on the occurrence of atherothrombotic events following lower extremity peripheral transluminal angioplasty (CLEAR-PATH)Emilien C J Wegerif, Çağdaş Ünlü, Manon I Generaal, et al.
EJVES Vascular Forum|January 26, 2026
Haemorrhagic Safety Update of CLEAR-PATH: 30 Day and 12 Month Antiplatelet Therapy After Peripheral AngioplastyEmilien C J Wegerif, Manon I Generaal, Linde J Vijn, et al.
BMJ Open|January 1, 2020
Safety of switching from vitamin K antagonist to non-vitamin K antagonist oral anticoagulant in frail elderly with atrial fibrillation: rationale and design of the FRAIL-AF randomised controlled trialLinda P T Joosten, Sander van Doorn, Arno W Hoes, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|May 15, 2024
Repeatability and reproducibility of the Forskolin-induced swelling (FIS) assay on intestinal organoids from people with Cystic FibrosisMarlou C Bierlaagh, Anabela S Ramalho, Iris A L Silva, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
BMC Medical Research Methodology|April 17, 2025
Cohort data with dropout: a simulation study comparing five longitudinal analysis methodsRebecca K Stellato, Rutger M van den Bor, Maria Schipper, et al.
Therapeutic Innovation & Regulatory Science|September 22, 2018
Efficient Source Data Verification Using Statistical Acceptance Sampling: A Simulation StudyRutger M van den Bor, Bas J Oosterman, Martinus B Oostendorp, et al.
Contemporary Clinical Trials Communications|April 27, 2018
Predicting enrollment performance of investigational centers in phase III multi-center clinical trialsRutger M van den Bor, Diederick E Grobbee, Bas J Oosterman, et al.
Journal of Clinical Epidemiology|April 17, 2017
A computationally simple central monitoring procedure, effectively applied to empirical trial data with known fraudRutger M van den Bor, Petrus W J Vaessen, Bas J Oosterman, et al.
ERJ Open Research|June 14, 2023
The RISE study protocol: resilience impacted by positive stressful events for people with cystic fibrosisEls van der Heijden, Rutger M van den Bor, Cornelis K van der Ent, et al.
American Heart Journal|April 12, 2024
Rationale and design for the randomized placebo-controlled double-blind trial studying the effect of single antiplatelet therapy (clopidogrel) versus dual antiplatelet therapy (clopidogrel/acetylsalicylic acid) on the occurrence of atherothrombotic events following lower extremity peripheral transluminal angioplasty (CLEAR-PATH)Emilien C J Wegerif, Çağdaş Ünlü, Manon I Generaal, et al.
EJVES Vascular Forum|January 26, 2026
Haemorrhagic Safety Update of CLEAR-PATH: 30 Day and 12 Month Antiplatelet Therapy After Peripheral AngioplastyEmilien C J Wegerif, Manon I Generaal, Linde J Vijn, et al.
BMJ Open|January 1, 2020
Safety of switching from vitamin K antagonist to non-vitamin K antagonist oral anticoagulant in frail elderly with atrial fibrillation: rationale and design of the FRAIL-AF randomised controlled trialLinda P T Joosten, Sander van Doorn, Arno W Hoes, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|May 15, 2024
Repeatability and reproducibility of the Forskolin-induced swelling (FIS) assay on intestinal organoids from people with Cystic FibrosisMarlou C Bierlaagh, Anabela S Ramalho, Iris A L Silva, et al.
Pageof 1